HCR Wealth Advisors

SEC CIK: 0001697715
Latest filing: Jul 13, 2026

SEC filings (opens in a new tab)

ABBV holding history

AbbVie Inc. in every 13F filed by HCR Wealth Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overview All 13F holders of ABBV Full Q2 2026 holdings

Shares (Q2 2026): 14,341
Value: $3.61M
% of portfolio: 0.3%
Quarters held: 22; Since Q1 2021

Holdings of ABBV by HCR Wealth Advisors, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	14,341	$3.61M	0.3%	+166+1.2%	Added	Holders
Q1 2026	14,175	$3.08M	0.3%	+103+0.7%	Added	Holders
Q4 2025	14,072	$3.22M	0.3%	+40.0%	Added	Holders
Q3 2025	14,068	$3.33M	0.3%	−243−1.7%	Reduced	Holders
Q2 2025	14,311	$2.66M	0.3%	+20+0.1%	Added	Holders
Q1 2025	14,291	$2.99M	0.4%	+56+0.4%	Added	Holders
Q4 2024	14,235	$2.53M	0.3%	+34+0.2%	Added	Holders
Q3 2024	14,201	$2.80M	0.4%	00.0%	Unchanged	Holders
Q2 2024	14,201	$2.44M	0.3%	−87−0.6%	Reduced	Holders
Q1 2024	14,288	$2.60M	0.4%	−325−2.2%	Reduced	Holders
Q4 2023	14,613	$2.26M	0.4%	+2,356+19.2%	Added	Holders
Q3 2023	12,257	$1.83M	0.4%	−3,448−22.0%	Reduced	Holders
Q2 2023	15,705	$2.12M	0.4%	−519−3.2%	Reduced	Holders
Q1 2023	16,224	$2.59M	0.5%	−363−2.2%	Reduced	Holders
Q4 2022	16,587	$2.68M	0.6%	−503−2.9%	Reduced	Holders
Q3 2022	17,090	$2.29M	0.5%	−432−2.5%	Reduced	Holders
Q2 2022	17,522	$2.68M	0.5%	−284−1.6%	Reduced	Holders
Q1 2022	17,806	$2.89M	0.5%	−12,762−41.7%	Reduced	Holders
Q4 2021	30,568	$4.14M	0.6%	−1,115−3.5%	Reduced	Holders
Q3 2021	31,683	$3.42M	0.6%	+75+0.2%	Added	Holders
Q2 2021	31,608	$3.56M	0.6%	+1,020+3.3%	Added	Holders
Q1 2021	30,588	$3.31M	0.7%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.